16-71626245-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052858.6(MARVELD3):āc.16G>Cā(p.Gly6Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,506,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052858.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARVELD3 | NM_052858.6 | c.16G>C | p.Gly6Arg | missense_variant | 1/3 | ENST00000268485.8 | |
MARVELD3 | NM_001017967.4 | c.16G>C | p.Gly6Arg | missense_variant | 1/3 | ||
MARVELD3 | NM_001271329.2 | c.16G>C | p.Gly6Arg | missense_variant | 1/3 | ||
MARVELD3 | XM_011523449.4 | c.16G>C | p.Gly6Arg | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARVELD3 | ENST00000268485.8 | c.16G>C | p.Gly6Arg | missense_variant | 1/3 | 1 | NM_052858.6 | P2 | |
ENST00000562763.1 | n.219+353C>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151800Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000560 AC: 6AN: 107194Hom.: 0 AF XY: 0.0000686 AC XY: 4AN XY: 58306
GnomAD4 exome AF: 0.000241 AC: 327AN: 1354730Hom.: 0 Cov.: 63 AF XY: 0.000242 AC XY: 161AN XY: 665184
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151800Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74134
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.16G>C (p.G6R) alteration is located in exon 1 (coding exon 1) of the MARVELD3 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the glycine (G) at amino acid position 6 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at